Louisiana State Employees Retirement System Raises Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Louisiana State Employees Retirement System grew its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 137.5% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 9,500 shares of the biotechnology company’s stock after acquiring an additional 5,500 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Axon Enterprise were worth $5,646,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in AXON. Geode Capital Management LLC increased its position in Axon Enterprise by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after acquiring an additional 35,320 shares during the period. Westfield Capital Management Co. LP increased its holdings in shares of Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares during the period. Champlain Investment Partners LLC lifted its holdings in shares of Axon Enterprise by 13.9% during the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after purchasing an additional 83,265 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Axon Enterprise by 1.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after buying an additional 9,090 shares during the last quarter. Finally, Groupama Asset Managment acquired a new position in Axon Enterprise in the 3rd quarter valued at $200,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Down 0.6 %

Shares of NASDAQ:AXON opened at $665.08 on Thursday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $50.71 billion, a P/E ratio of 171.86, a P/E/G ratio of 6.79 and a beta of 1.05. Axon Enterprise, Inc. has a 52-week low of $255.68 and a 52-week high of $698.67. The stock’s fifty day simple moving average is $623.80 and its 200-day simple moving average is $502.57.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on AXON shares. Robert W. Baird boosted their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. The Goldman Sachs Group lifted their price objective on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. JMP Securities increased their target price on Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a research note on Tuesday, February 4th. Northland Securities lifted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Finally, Needham & Company LLC upped their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. One equities research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $542.15.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now directly owns 2,392 shares in the company, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 8,711 shares of company stock valued at $5,631,561. 6.10% of the stock is owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.